ZA947240B - Transdermal therapeutic system comprising the active substance acetylsalicylic acid - Google Patents

Transdermal therapeutic system comprising the active substance acetylsalicylic acid

Info

Publication number
ZA947240B
ZA947240B ZA947240A ZA947240A ZA947240B ZA 947240 B ZA947240 B ZA 947240B ZA 947240 A ZA947240 A ZA 947240A ZA 947240 A ZA947240 A ZA 947240A ZA 947240 B ZA947240 B ZA 947240B
Authority
ZA
South Africa
Prior art keywords
active substance
acetylsalicylic acid
pct
therapeutic system
transdermal therapeutic
Prior art date
Application number
ZA947240A
Other languages
English (en)
Inventor
Michael Hortsmann
Gerd Hoffmann
Heinrich Kindel
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA947240B publication Critical patent/ZA947240B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA947240A 1993-09-22 1994-09-19 Transdermal therapeutic system comprising the active substance acetylsalicylic acid ZA947240B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4332093A DE4332093C2 (de) 1993-09-22 1993-09-22 Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ZA947240B true ZA947240B (en) 1995-05-22

Family

ID=6498226

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA947240A ZA947240B (en) 1993-09-22 1994-09-19 Transdermal therapeutic system comprising the active substance acetylsalicylic acid

Country Status (18)

Country Link
US (1) US5716636A (fr)
EP (1) EP0720479B1 (fr)
JP (1) JPH09503755A (fr)
AT (1) ATE244012T1 (fr)
AU (1) AU684838B2 (fr)
CZ (1) CZ290324B6 (fr)
DE (2) DE4332093C2 (fr)
ES (1) ES2202327T3 (fr)
FI (1) FI961282A (fr)
HU (1) HUT73441A (fr)
IL (1) IL110989A (fr)
MY (1) MY111126A (fr)
NO (1) NO309175B1 (fr)
NZ (1) NZ273944A (fr)
PL (1) PL313327A1 (fr)
SK (1) SK282073B6 (fr)
WO (1) WO1995008330A1 (fr)
ZA (1) ZA947240B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
US6071896A (en) * 1992-06-16 2000-06-06 Gundersen Clinic, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
GB9425783D0 (en) * 1994-12-21 1995-02-22 Ethical Pharma Ltd Packaging of patches
GB2319473A (en) * 1995-07-27 1998-05-27 Cal Int Ltd Transdemal patch containing aspirin
GR1002807B (el) 1996-06-20 1997-11-13 Lavipharm A.E. Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
DE19701059C2 (de) * 1997-01-15 2000-12-21 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes transdermales therapeutisches System mit Resorptionsverstärkung
JPH1112177A (ja) 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
DE19837764C1 (de) * 1998-08-20 2000-03-16 Lohmann Therapie Syst Lts Verfahren zum Herstellen von klebenden Stanzlingen aus einer endlosen Bahn und nach dem Verfahren hergestellter Stanzling
NZ515953A (en) 1999-07-02 2003-06-30 Lts Lohmann Therapie System Ag Microreservoir system on the basis of polysiloxanes and ambiphilic solvents
DE19949252B4 (de) * 1999-10-13 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung
DE19949202A1 (de) * 1999-10-13 2001-05-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure
DE19959913A1 (de) * 1999-12-11 2001-06-28 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne
DE10034802A1 (de) * 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
DE10102817B4 (de) * 2001-01-23 2006-01-12 Lts Lohmann Therapie-Systeme Ag Vorrichtung und Verfahren zur Hitzepulsgestützten transdermalen Applikation von Wirkstoffen
DE10118282A1 (de) * 2001-04-12 2002-12-05 Lohmann Therapie Syst Lts Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
US20080319068A1 (en) * 2005-04-27 2008-12-25 Transform Pharmaceuticals, Inc. Novel Polymorph of Acetylsalicylic Acid, and Methods of Making and Using the Same
DE102006026578B4 (de) 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
US8778387B2 (en) * 2009-09-02 2014-07-15 Hyprotek, Inc. Antimicrobial medical dressings and protecting wounds and catheter sites
DE102009056746A1 (de) * 2009-12-04 2011-06-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung von Peptiden
WO2011091322A2 (fr) 2010-01-22 2011-07-28 Hyprotek, Inc. Agents antimicrobiens et procédés d'utilisation associés
US9039967B2 (en) 2012-02-06 2015-05-26 Hyprotek, Inc. Antiseptic applicators and packaging techniques
AU2016314621B2 (en) * 2015-09-04 2021-05-13 Poli Md S.R.L. Composition and medical device comprising acetylsalicylic acid for the treatment of human papilloma virus skin infections
HUP2200237A2 (hu) * 2022-06-27 2023-12-28 Pecsi Tudomanyegyetem Alacsony dózisú, stabil hatóanyag-leadású transzdermális készítmény és tapasz, valamint eljárás ezek elõállítására

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012508A (en) * 1975-02-03 1977-03-15 Burton Verna M Topical composition and method
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4460368A (en) * 1981-10-29 1984-07-17 Almedco, Inc. Trans-dermal medication system
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
ATE42901T1 (de) * 1984-03-05 1989-05-15 Nitto Denko Corp Haftendes arzneimittelpraeparat fuer perkutane absorption.
HU197519B (en) * 1987-06-22 1989-04-28 Biogal Gyogyszergyar Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
JPH03112926A (ja) * 1989-09-26 1991-05-14 Kyowa Hakko Kogyo Co Ltd 経皮吸収製剤
ATE183639T1 (de) * 1991-02-18 1999-09-15 Commw Scient Ind Res Org Zusammensetzung zur verwendung in der transdermalen verabreichung
HRP921157A2 (en) * 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy

Also Published As

Publication number Publication date
DE4332093A1 (de) 1995-03-23
EP0720479B1 (fr) 2003-07-02
NO961155D0 (no) 1996-03-21
SK35396A3 (en) 1996-12-04
AU684838B2 (en) 1998-01-08
CZ290324B6 (cs) 2002-07-17
DE59410303D1 (de) 2003-08-07
HUT73441A (en) 1996-07-29
US5716636A (en) 1998-02-10
NO961155L (no) 1996-03-21
DE4332093C2 (de) 1995-07-13
PL313327A1 (en) 1996-06-24
WO1995008330A1 (fr) 1995-03-30
FI961282A (fi) 1996-05-17
AU7782794A (en) 1995-04-10
FI961282A0 (fi) 1996-03-20
NO309175B1 (no) 2000-12-27
MY111126A (en) 1999-08-30
ES2202327T3 (es) 2004-04-01
IL110989A0 (en) 1994-11-28
EP0720479A1 (fr) 1996-07-10
ATE244012T1 (de) 2003-07-15
JPH09503755A (ja) 1997-04-15
HU9600719D0 (en) 1996-05-28
SK282073B6 (sk) 2001-10-08
CZ86496A3 (en) 1996-06-12
IL110989A (en) 1998-12-06
NZ273944A (en) 1997-10-24

Similar Documents

Publication Publication Date Title
ZA947240B (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid
CA2227202A1 (fr) Systeme therapeutique transdermique pour l'administration par la peau de principes actifs dans le corps humain
MY111688A (en) Transdermal therapeutic system comprising the active substance 17-b-estradiol (anhydous)
PL319013A1 (en) Transdermal therapeutic system containing estradiol and water bonding additives
CA2172401A1 (fr) Systeme therapeutique transdermique avec l'acide acetylsalicylique comme substance active
CA2197865A1 (fr) Systeme therapeutique transdermique renfermant de l'oestradiol et des additifs hydrophiles
YU49193A (sh) Transdermalni terapijski sistem sa aktivnom materijom bezvodnim 17-beta-estradiolom